ICICI Bank and Tata Memorial Centre (TMC) lay foundation stone for advanced cancer care block in Visakhapatnam

June 12, 2025

• ICICI Bank commits over ₹550 crore to TMC to expand cancer care in the city

• Part of the Bank’s ₹1,800 crore contribution to TMC, the block will be among the largest facilities in eastern India for child and blood cancer treatment 

Visakhapatnam: ICICI Bank, in collaboration with Tata Memorial Centre (TMC), today announced commencement of the construction of a new building at the Homi Bhabha Cancer Hospital and Research Centre (HBCHRC) in Visakhapatnam, Andhra Pradesh.

With a commitment of over ₹550 crore, the Bank is funding the construction of a state-of-the-art facility spanning nearly 3.9 lakh square feet, equipped with cutting-edge medical technology.

Once operational, the eight-storied new building-- ICICI Foundation Block for Child and Blood Cancer—will serve 3,000 patients annually. Currently, HBCHRC, Visakhapatnam has a capacity of handling 6,200 patients annually.

Designed as one of the largest specialised cancer facilities in eastern India, the new building will house over 215 beds. It is expected to be completed by 2027, subject to necessary approvals. ICICI Foundation for Inclusive Growth, the CSR arm of ICICI Bank, will oversee its implementation.

The foundation stone was unveiled by Mr. Pradeep Kumar Sinha, Chairman, ICICI Bank; in the presence of Mr. Sandeep Batra, Executive Director, ICICI Bank; and Dr. Sudeep Gupta, Director, Tata Memorial Centre, Mumbai.

Mr. Sinha also inaugurated the N.K. Rao Auditorium in the presence of other dignitaries. ICICI Foundation has supported TMC with infrastructure and equipment for the new auditorium.

Mr. Pradeep Kumar Sinha, Chairman, ICICI Bank said, “We are honoured to partner with TMC in a mission towards cancer care, that aligns with our philosophy of strengthening critical healthcare infrastructure in the country. This project reflects our commitment to enabling accessible and high-quality medical care for individuals in need. This project, one of the largest in eastern corridor for child and blood cancer, will serve patients from Andhra Pradesh and nearby eastern states, helping address the growing need for cancer treatment.”

On the occasion, Mr. Sandeep Batra, Executive Director, ICICI Bank stated, “At ICICI Bank, healthcare remains a focus of our CSR initiatives. Two years ago, we announced our partnership with TMC, an institution that has made a profound impact on cancer care in India, by committing ₹1,200 crore to set up three new blocks at TMC’s centres in Visakhapatnam, Navi Mumbai, and New Chandigarh. Recognising TMC’s latest requirements, we are pleased to enhance our commitment to ₹1,800 crore. Spanning a total area of 10.7 lakh square feet, these new blocks are designed to be equipped with state-of-the-art medical facilities and research wings. These blocks will together accommodate 19 LINACs* and 555 beds. Once fully operational, they will serve as regional hubs.”

Dr. Umesh Mahantshetty, Director, Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam said, “We are grateful to ICICI Foundation for their generous donation, which will significantly contribute to the advancement of cancer treatment and research in Pediatric and Hematolymphoid Cancers in this region. The partnership with ICICI Foundation is a testament to the collective efforts of our institutions in providing top-notch care and improving cancer outcomes for patients across the country."

Dr. Girish Chinnaswamy, Professor & Head, Paediatric Oncology, Tata Memorial Hospital, Mumbai said, “Paediatric & Hematolymphoid Cancers require specialised care in terms of diagnosis, evaluation, treatment, support services including blood centre, nutrition, rehabilitation etc. and expertise. At HBCHRC Visakhapatnam currently, we have been registering approximately 200 new Paediatric cancer and 350-400 Hematolymphoid cancer patients every year in the past 3 years. With the new block added we will be able to augment the existing services substantially including expansion of bone marrow transplant programme and also initiate immunotherapy. This will also provide ample opportunities to undertake research related to patients in this region.”

ICICI Bank’s commitment of ₹550 crore for the Visakhapatnam hospital is a part of the expanded contribution of ₹1,800 crore.

The ICICI Foundation Child and Blood Cancer Block at Visakhapatnam will offer comprehensive treatment options, including:

• Intensive chemotherapy, bone marrow transplantation, and advanced radiation therapy

• Cutting-edge immunotherapies like CAR-T cell therapy

• High-end medical imaging and diagnostics, including three LINAC*, MRI, and CVT-PET scans

• 14 BMT (Bone Marrow Transplant) Rooms, 14 ICUs, 5 Operating theatres

• There will be research laboratories and joint discussion facilities for treatment planning and training

*Linear Accelerators (LINACs) targets radiation at the cancer cells with accuracy, sparing the adjoining healthy tissues.

About ICICI Bank: ICICI Bank Ltd (BSE: ICICIBANK, NSE: ICICIBANK and NYSE:IBN) is a leading private sector bank in India. The Bank’s total assets stood at ₹ 21,18,240 crore at March 31, 2025.

About ICICI Foundation: ICICI Bank set up ICICI Foundation for Inclusive Growth in 2008 to strengthen and broaden its commitment to social development. ICICI Foundation operates in environment protection, livelihood enhancement and skill development for the underprivileged communities, affordable healthcare, and financial inclusion across India. As part of its environmental efforts, ICICI Foundation has facilitated planting of 4.9 million trees and the harvesting of 33.87 billion litres of water annually. The Foundation has supported 2.5 million individuals with healthcare services and its livelihood programmes have empowered 9.1 million people with sustainable opportunities. As on March 31, 2025, ICICI Foundation’s initiatives have positively impacted over 19 million lives, reinforcing its commitment to inclusive and sustainable growth.

About Tata Memorial Centre: Tata Memorial Centre (TMC) was established by the House of Tata as the National Comprehensive Cancer Centre in 1941. In 1962 the centre came under the guardianship of the Department of Atomic energy (DAE), Govt. of India as an autonomous grant-in-aid institution. Tata Memorial Centre is one of India's oldest and largest cancer centres, with over 75 years of exceptional patient care, high-quality training, and innovative cancer research.

For news and updates, visit www.icicibank.com and follow us on X (Formerly Twitter) at www.twitter.com/ICICIBank

For media queries, write to: corporate.communications@icicibank.com

Certain statements in this release relating to a future period of time (including inter alia concerning our future business plans or growth prospects) are forward-looking statements intended to qualify for the 'safe harbor' under applicable securities laws including the US Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. These risks and uncertainties include, but are not limited to statutory and regulatory changes, international economic and business conditions; political or economic instability in the jurisdictions where we have operations, increase in non - performing loans, unanticipated changes in interest rates, foreign exchange rates, equity prices or other rates or prices, our growth and expansion in business, the adequacy of our allowance for credit losses, the actual growth in demand for banking products and services, investment income, cash flow projections, our exposure to market risks, changes in India’s sovereign rating, as well as other risks detailed in the reports filed by us with the United States Securities and Exchange Commission. Any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of the date of this release. ICICI Bank undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date thereof. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at 
www.sec.gov

pdf version